124 related articles for article (PubMed ID: 1587751)
1. Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas.
Mohiuddin M; Rosato F; Barbot D; Schuricht A; Biermann W; Cantor R
Int J Radiat Oncol Biol Phys; 1992; 23(2):305-11. PubMed ID: 1587751
[TBL] [Abstract][Full Text] [Related]
2. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas.
Mohiuddin M; Cantor RJ; Biermann W; Weiss SM; Barbot D; Rosato FE
Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):79-84. PubMed ID: 3121546
[TBL] [Abstract][Full Text] [Related]
3. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study.
Nori D; Merimsky O; Osian AD; Heffernan M; Cortes E; Turner JW
J Surg Oncol; 1996 Apr; 61(4):300-5. PubMed ID: 8628003
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.
Schuricht AL; Spitz F; Barbot D; Rosato F
Am Surg; 1998 Nov; 64(11):1043-9. PubMed ID: 9798766
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of the pancreas--the Jefferson experience 1975-1988.
Mohiuddin M; Rosato F; Schuricht A; Barbot D; Biermann W; Cantor R
Eur J Surg Oncol; 1994 Feb; 20(1):13-20. PubMed ID: 8131862
[TBL] [Abstract][Full Text] [Related]
6. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas.
Mohiuddin M; Regine WF; Stevens J; Rosato F; Barbot D; Biermann W; Cantor R
J Clin Oncol; 1995 Nov; 13(11):2764-8. PubMed ID: 7595736
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
[TBL] [Abstract][Full Text] [Related]
9. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
[TBL] [Abstract][Full Text] [Related]
10. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
Cohen SJ; Dobelbower R; Lipsitz S; Catalano PJ; Sischy B; Smith TJ; Haller DG;
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1345-50. PubMed ID: 16029791
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
14. 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree.
Dobelbower RR; Merrick HW; Ahuja RK; Skeel RT
Cancer; 1986 Nov; 58(10):2185-95. PubMed ID: 3756765
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study.
Jin Z; Du Y; Li Z; Jiang Y; Chen J; Liu Y
Endoscopy; 2008 Apr; 40(4):314-20. PubMed ID: 18283622
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
Yeung RS; Weese JL; Hoffman JP; Solin LJ; Paul AR; Engstrom PF; Litwin S; Kowalyshyn MJ; Eisenberg BL
Cancer; 1993 Oct; 72(7):2124-33. PubMed ID: 8374871
[TBL] [Abstract][Full Text] [Related]
18. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer.
Alden ME; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):945-51. PubMed ID: 8138448
[TBL] [Abstract][Full Text] [Related]
19. Combined modality therapy for stage II and stage III pancreatic carcinoma.
Kamthan AG; Morris JC; Dalton J; Mandeli JP; Chesser MR; Leben D; Cooperman A; Bruckner HW
J Clin Oncol; 1997 Aug; 15(8):2920-7. PubMed ID: 9256136
[TBL] [Abstract][Full Text] [Related]
20. Multimodality therapy of localized unresectable pancreatic adenocarcinoma.
Whittington R; Solin L; Mohiuddin M; Cantor RI; Rosato FE; Biermann WA; Weiss SM; Pajak TF
Cancer; 1984 Nov; 54(9):1991-8. PubMed ID: 6478433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
